Corcept Therapeutics (CORT) Announces 11M Common Offering

Article Stock Quotes (1) Comments (0)

Corcept Therapeutics Incorporated (Nasdaq: CORT), is offering to issue and sell 11,000,000 shares of its common stock in an underwritten public offering. Credit Suisse Securities (USA) LLC is acting as sole book-running manager and underwriter in the offering. The last reported sale price of its common stock on June 29, 2012 was $4.49 per share. Corcept also intends to grant the underwriter a 30 day option to purchase up to an additional 15% of the shares of common stock offered in the public offering.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Calumet Specialty Products (CLMT) Files $300M Common, Debt Shelf
• Cubic (CUB) Prices 2.32M Common Secondary Offering
• Cyclacel (CYCC) Prices 6.67M Common Stock Offering

Create E-mail Alert Related Categories

Equity Offerings

Related Entities

Credit Suisse

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?